Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Infectious Respiratory Disease Diagnostics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Infectious Respiratory Disease Diagnostics Market, by Product Type, 2019-2029 (USD Billion)
1.2.3. Infectious Respiratory Disease Diagnostics Market, by Sample Type, 2019-2029 (USD Billion)
1.2.4. Infectious Respiratory Disease Diagnostics Market, by Technology, 2019-2029 (USD Billion)
1.2.5. Infectious Respiratory Disease Diagnostics Market, by Application, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Infectious Respiratory Disease Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Infectious Respiratory Disease Diagnostics Market Dynamics
3.1. Infectious Respiratory Disease Diagnostics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidences of infectious respiratory diseases
3.1.1.2. Rising penetration of molecular techniques
3.1.2. Market Challenges
3.1.2.1. High prices of diagnostic products
3.1.2.2. Presence of stringent regulatory frameworks
3.1.3. Market Opportunities
3.1.3.1. Increasing technological advancement in respiratory disease testing
3.1.3.2. Growing R&D investments in respiratory disease testing
Chapter 4. Global Infectious Respiratory Disease Diagnostics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Infectious Respiratory Disease Diagnostics Market, by Product Type
6.1. Market Snapshot
6.2. Global Infectious Respiratory Disease Diagnostics Market by Product Type, Performance - Potential Analysis
6.3. Global Infectious Respiratory Disease Diagnostics Market Estimates & Forecasts by Product Type 2019-2029 (USD Billion)
6.4. Infectious Respiratory Disease Diagnostics Market, Sub Segment Analysis
6.4.1. Instruments
6.4.2. Consumables
6.4.3. Services
Chapter 7. Global Infectious Respiratory Disease Diagnostics Market, by Sample Type
7.1. Market Snapshot
7.2. Global Infectious Respiratory Disease Diagnostics Market by Sample Type, Performance - Potential Analysis
7.3. Global Infectious Respiratory Disease Diagnostics Market Estimates & Forecasts by Sample Type 2019-2029 (USD Billion)
7.4. Infectious Respiratory Disease Diagnostics Market, Sub Segment Analysis
7.4.1. Saliva
7.4.2. Nasopharyngeal Swabs (NPS)
7.4.3. Anterior Nasal Region
7.4.4. Blood
7.4.5. Others
Chapter 8. Global Infectious Respiratory Disease Diagnostics Market, by Technology
8.1. Market Snapshot
8.2. Global Infectious Respiratory Disease Diagnostics Market by Technology, Performance - Potential Analysis
8.3. Global Infectious Respiratory Disease Diagnostics Market Estimates & Forecasts by Technology 2019-2029 (USD Billion)
8.4. Infectious Respiratory Disease Diagnostics Market, Sub Segment Analysis
8.4.1. Immunoassay
8.4.2. Molecular Diagnostics
8.4.3. Microbiology
8.4.4. Other Technologies
Chapter 9. Global Infectious Respiratory Disease Diagnostics Market, by Application
9.1. Market Snapshot
9.2. Global Infectious Respiratory Disease Diagnostics Market by Application, Performance - Potential Analysis
9.3. Global Infectious Respiratory Disease Diagnostics Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
9.4. Infectious Respiratory Disease Diagnostics Market, Sub Segment Analysis
9.4.1. COVID-19
9.4.2. Influenza
9.4.3. Respiratory Syncytial Virus (RSV)
9.4.4. Tuberculosis
9.4.5. Streptococcus Testing
9.4.6. Other Respiratory Disease Testing
Chapter 10. Global Infectious Respiratory Disease Diagnostics Market, Regional Analysis
10.1. Infectious Respiratory Disease Diagnostics Market, Regional Market Snapshot
10.2. North America Infectious Respiratory Disease Diagnostics Market
10.2.1. U.S. Infectious Respiratory Disease Diagnostics Market
10.2.1.1. Product Type breakdown estimates & forecasts, 2019-2029
10.2.1.2. Sample Type breakdown estimates & forecasts, 2019-2029
10.2.1.3. Technology breakdown estimates & forecasts, 2019-2029
10.2.1.4. Application breakdown estimates & forecasts, 2019-2029
10.2.2. Canada Infectious Respiratory Disease Diagnostics Market
10.3. Europe Infectious Respiratory Disease Diagnostics Market Snapshot
10.3.1. U.K. Infectious Respiratory Disease Diagnostics Market
10.3.2. Germany Infectious Respiratory Disease Diagnostics Market
10.3.3. France Infectious Respiratory Disease Diagnostics Market
10.3.4. Spain Infectious Respiratory Disease Diagnostics Market
10.3.5. Italy Infectious Respiratory Disease Diagnostics Market
10.3.6. Rest of Europe Infectious Respiratory Disease Diagnostics Market
10.4. Asia-Pacific Infectious Respiratory Disease Diagnostics Market Snapshot
10.4.1. China Infectious Respiratory Disease Diagnostics Market
10.4.2. India Infectious Respiratory Disease Diagnostics Market
10.4.3. Japan Infectious Respiratory Disease Diagnostics Market
10.4.4. Australia Infectious Respiratory Disease Diagnostics Market
10.4.5. South Korea Infectious Respiratory Disease Diagnostics Market
10.4.6. Rest of Asia Pacific Infectious Respiratory Disease Diagnostics Market
10.5. Latin America Infectious Respiratory Disease Diagnostics Market Snapshot
10.5.1. Brazil Infectious Respiratory Disease Diagnostics Market
10.5.2. Mexico Infectious Respiratory Disease Diagnostics Market
10.6. Rest of The World Infectious Respiratory Disease Diagnostics Market
Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Abbott
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Thermo Fisher Scientific, Inc.
11.2.3. Koninklijke Philips N.V.
11.2.4. F. Hoffmann-La Roche Ltd.
11.2.5. bioMerieux SA
11.2.6. Bio-Rad Laboratories, Inc.
11.2.7. Quidel Corporation
11.2.8. Siemens Healthcare GmbH
11.2.9. Danaher
11.2.10. Qiagen
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption